While TOPK expression is low or undetectable in healthy tissues,9 it is overexpressed in lung cancer, ovarian cancer, renal cancer, colorectal cancer, prostate cancer and haematologic malignancies and correlates with worse outcomes.11, 14, 15, 16, 17, 18, 19. This evidence concerns the gene PBK and ovarian carcinoma.